IQVIA (IQV) Expected to Announce Quarterly Earnings on Wednesday

IQVIA (NYSE:IQV) is projected to release its earnings data before the market opens on Wednesday, February 12th. Analysts expect IQVIA to post earnings of $3.11 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

IQVIA Trading Up 0.4 %

NYSE:IQV opened at $200.00 on Wednesday. The firm has a 50 day moving average of $200.31 and a 200 day moving average of $220.14. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA has a 52 week low of $187.62 and a 52 week high of $261.73. The stock has a market capitalization of $36.30 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 2.15 and a beta of 1.48.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on IQV shares. Barclays lowered their price objective on IQVIA from $255.00 to $235.00 and set an “overweight” rating for the company in a research report on Monday. Leerink Partners restated an “outperform” rating and set a $248.00 price target (down previously from $260.00) on shares of IQVIA in a research note on Tuesday, November 19th. TD Cowen decreased their price objective on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. JPMorgan Chase & Co. dropped their target price on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. Finally, Truist Financial cut their price target on shares of IQVIA from $265.00 to $261.00 and set a “buy” rating on the stock in a research note on Thursday, December 12th. Five research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $254.53.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.